Category: Regenerons
-
Wall Street dives into Regeneron’s robust prospects By Investing.com
•
Regeneron (NASDAQ:) Pharmaceuticals, Inc. remains… At the forefront of the biopharmaceutical industry, with a strategic focus on new therapeutic areas and a strong financial position. Analysts from BMO Capital Markets, Morgan Stanley and RBC Capital Markets provide insights into the company’s growth potential, competitive position and market dynamics, as Regeneron…